<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://boldinvestors.com.au/news/vectus-biosystems-vbs-granted-fda-pre-ind-meeting-for-vb0004</loc>
    <news:news>
      <news:publication>
        <news:name>Bold Investors</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T00:14:00.000Z</news:publication_date>
      <news:title>Vectus Biosystems (ASX: VBS) Granted FDA Pre-IND Meeting for VB0004</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://boldinvestors.com.au/news/true-north-copper-tnc-hits-11m-at-4-23-cueq-at-cloncurry</loc>
    <news:news>
      <news:publication>
        <news:name>Bold Investors</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T00:08:00.000Z</news:publication_date>
      <news:title>True North Copper (ASX: TNC) Hits 11m at 4.23% CuEq at Cloncurry</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://boldinvestors.com.au/news/argent-biopharma-rgt-licences-nlc-antiviral-portfolio</loc>
    <news:news>
      <news:publication>
        <news:name>Bold Investors</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29T00:05:00.000Z</news:publication_date>
      <news:title>Argent BioPharma (ASX: RGT) Licences NLC Antiviral Portfolio</news:title>
    </news:news>
  </url>
</urlset>
